Clémence Basse
Impact in
-
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
Papers in
- Neurology 12
- Myasthenia Gravis and Thymoma 12
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Michel Arock (1 shared paper)Nicolas Girard (22 shared papers)Pierre‐Emmanuel Bonté (3 shared papers)Xavier Paolettí (1 shared paper)Keith J. Killian (1 shared paper)Luc Cabel (1 shared paper)Jeffrey S. Ross (1 shared paper)Maxime Frélaut (1 shared paper)
In The Last Decade
Clémence Basse
33 papers receiving 490 citations
Peers
Comparison fields: 5 of 50
- Oncology 163
- Drug Discovery 2
- Neurology 85
- Cancer Research 52
- Pulmonary and Respiratory Medicine 105
Countries citing papers authored by Clémence Basse
This map shows the geographic impact of Clémence Basse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clémence Basse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clémence Basse more than expected).
Fields of papers citing papers by Clémence Basse
This network shows the impact of papers produced by Clémence Basse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clémence Basse. The network helps show where Clémence Basse may publish in the future.
Co-authors
The 25 scholars most cited alongside Clémence Basse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 88 | |
| 2 | 2014 | 75 | |
| 3 | 2023 | 56 | |
| 4 | 2018 | 44 | |
| 5 | 2020 | 44 | |
| 6 | 2022 | 32 | |
| 7 | 2017 | 31 | |
| 8 | 2022 | 24 | |
| 9 | 2019 | 14 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 6 | |
| 15 | 2024 | 6 | |
| 16 | 2017 | 5 | |
| 17 | 2024 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2023 | 4 |
About Clémence Basse
Clémence Basse is a scholar working on Neurology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Dermatology, having authored 38 papers that have together received 501 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Myasthenia Gravis and Thymoma (12 papers), Lung Cancer Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), COVID-19 and healthcare impacts (3 papers), Cancer Genomics and Diagnostics (2 papers), Epigenetics and DNA Methylation (1 paper) and Telemedicine and Telehealth Implementation (1 paper). The work is most often cited by research in Oncology (163 citations), Drug Discovery (2 citations), Neurology (85 citations), Cancer Research (52 citations) and Pulmonary and Respiratory Medicine (105 citations). Clémence Basse has collaborated with scholars based in France, Spain and Belgium. Frequent co-authors include Michel Arock, Nicolas Girard, Pierre‐Emmanuel Bonté, Xavier Paolettí, Keith J. Killian, Luc Cabel, Jeffrey S. Ross, Maxime Frélaut, François‐Clément Bidard and Audrey Bellesœur. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Annals of Oncology, Clinical Lung Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.